1. USRDS 1999 Point Prevalence Counts by Modality, Data Source, and Year, 1988-97 Count (1000s) Year Center Hemo Functioning Transplant PD Home Hemo Facility Survey (FS) USRDS Database * * Preliminary USRDS/FS 191.9/199.7 86.4 26.7/30.0 1.7/1.9 III-1

2. Distribution of Point Prevalent ESRD Patients by Treatment Modality and Year, 1988-97 Year * Preliminary * ESRD Patients (%) Center Hemo Functioning Transplant PD Home Hemo 62.3% 28.1% 8.7% 0.6% III-2 USRDS 1999

3. Distribution of Point Prevalent Dialysis Patients on December 31 by Year*, 1988-97 *Center Hemodialysis (not shown) = 80-84% ** Preliminary Dialysis Patients (%) Year CAPD CCPD Unspecified Dialysis Home Hemo ** 7.6% 4.4% 0.8% 0.7% III-3 USRDS 1999

4. Patients on Waiting List for Kidney Transplant and Cadaveric Donor Transplants by Year, 1988-97 Transplants or Patients Awaiting Transplant (1000s) Year On Waiting List Cadaveric Donor Transplants 36,036 8,479 III-4 USRDS 1999

5. Transplants by Donor Source and Year, 1989-97 * Preliminary Year Transplants (1000s) Cadaveric Living Related Living Unrelated * 8,523 3,217 705 III-5 USRDS 1999

6. Dialysis Modality by Race, 1997 * Race * Preliminary Prevalent Patients (%) Remainder due to Home HD and Uncertain Dialysis III-6 USRDS 1999

7. Dialysis Modality by Age, 1997* Age * Preliminary Prevalent Patients (%) III-7 Remainder due to Home HD and Uncertain Dialysis USRDS 1999

8. Delivered Dialysis Dose * for Hemodialysis Patients by Year, 1986-97 Kt/V (Delivered) *Daugirdas corrected Kt/V USRDS Special Study Year(s) **Source: HCFA 1998 ESRD Core Indicators Report; average of 1996 and 1997 INC PREV III-8 USRDS 1999

9. Year URR (%) Average Urea Reduction Ratio (URR) by Year*, 1993-97 *Source: HCFA 1998 ESRD Core Indicators Report III-9 USRDS 1999

10. Average Weekly Kt/V Urea*Average Weekly C. Creat.* † Year † (L/week/1.73m 2) * Source: HCFA 1998 ESRD Core Indicators Report Average Weekly Kt/V Urea and Creatinine Clearance for CAPD Patients, by Year, 1995-98 III-10 USRDS 1999

11. Dialysis Membrane Type Used for Incident HD Patients by Year, 1990-97 Patients with missing membrane type are excluded. USRDS Special Study Year(s) III-11 CMAS DMMS W-1 DMMS W-2 Synthetic Cellulose Modified Cellulose 14 2 16 67 32 27 4 16 21 HF LF Incident HD Patients (%) USRDS 1999 100 80 60 40 20 0 HF

12. Membrane Type* by Census Region, 1996-97 Census Region * On about day 60 of ESRD from DMMS Wave 2 Incident HD Patients (%) III-12 100 80 60 40 20 0 USRDS 1999

13. Hematocrit in Hemodialysis Patients, 1989-97 Average Hematocrit (Vol. %) Prevalent on EPO *HCFA 1998 ESRD Core Indicators Report Year 1989199790939291969594 III-13 All Prevalent at Year End* All Incident (Medical Evidence Form) USRDS 1999